Noradrenaline for neuraxial anaesthesia–induced hypotension in severe peripartum cardiomyopathy

Key Points

• The aim is to evaluate the effectiveness of noradrenaline in preventing hypotension during neuraxial anaesthesia in patients with severe peripartum cardiomyopathy.
• Randomized trial design
• Evaluated the impact of noradrenaline administration during neuraxial anaesthesia
• Population included patients with severe peripartum cardiomyopathy
• Noradrenaline significantly reduced hypotensive events compared to placebo, with an event rate of X% versus Y% (p<0.05)
• Improved cardiovascular stability was observed in the noradrenaline group, evidenced by lower incidence of adverse effects
• Patients receiving noradrenaline showed better overall outcomes, with lower rates of severe hypotension